Logo image of NTES

NETEASE INC-ADR (NTES) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NTES - US64110W1027 - ADR

137.96 USD
-0.11 (-0.08%)
Last: 12/29/2025, 9:54:28 AM
Fundamental Rating

7

Overall NTES gets a fundamental rating of 7 out of 10. We evaluated NTES against 80 industry peers in the Entertainment industry. NTES has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NTES scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make NTES suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year NTES was profitable.
NTES had a positive operating cash flow in the past year.
In the past 5 years NTES has always been profitable.
Each year in the past 5 years NTES had a positive operating cash flow.
NTES Yearly Net Income VS EBIT VS OCF VS FCFNTES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

NTES has a better Return On Assets (16.92%) than 92.50% of its industry peers.
The Return On Equity of NTES (23.22%) is better than 90.00% of its industry peers.
The Return On Invested Capital of NTES (17.58%) is better than 93.75% of its industry peers.
NTES had an Average Return On Invested Capital over the past 3 years of 14.54%. This is significantly above the industry average of 8.70%.
The last Return On Invested Capital (17.58%) for NTES is above the 3 year average (14.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.92%
ROE 23.22%
ROIC 17.58%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
NTES Yearly ROA, ROE, ROICNTES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

NTES has a better Profit Margin (32.45%) than 97.50% of its industry peers.
NTES's Profit Margin has declined in the last couple of years.
The Operating Margin of NTES (31.60%) is better than 98.75% of its industry peers.
In the last couple of years the Operating Margin of NTES has grown nicely.
NTES has a better Gross Margin (63.47%) than 70.00% of its industry peers.
In the last couple of years the Gross Margin of NTES has grown nicely.
Industry RankSector Rank
OM 31.6%
PM (TTM) 32.45%
GM 63.47%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
NTES Yearly Profit, Operating, Gross MarginsNTES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

NTES has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, NTES has less shares outstanding
Compared to 5 years ago, NTES has less shares outstanding
The debt/assets ratio for NTES has been reduced compared to a year ago.
NTES Yearly Shares OutstandingNTES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTES Yearly Total Debt VS Total AssetsNTES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

NTES has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
NTES has a better Debt to FCF ratio (0.16) than 91.25% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that NTES is not too dependend on debt financing.
NTES has a better Debt to Equity ratio (0.05) than 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.16
Altman-Z N/A
ROIC/WACC1.93
WACC9.1%
NTES Yearly LT Debt VS Equity VS FCFNTES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 3.42 indicates that NTES has no problem at all paying its short term obligations.
The Current ratio of NTES (3.42) is better than 87.50% of its industry peers.
A Quick Ratio of 3.41 indicates that NTES has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.41, NTES belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.41
NTES Yearly Current Assets VS Current LiabilitesNTES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.11% over the past year.
The Earnings Per Share has been growing by 17.51% on average over the past years. This is quite good.
Looking at the last year, NTES shows a small growth in Revenue. The Revenue has grown by 5.81% in the last year.
NTES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.19% yearly.
EPS 1Y (TTM)29.11%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%26.66%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%8.2%

3.2 Future

NTES is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -26.15% yearly.
The Revenue is expected to grow by 9.64% on average over the next years. This is quite good.
EPS Next Y20.61%
EPS Next 2Y13.01%
EPS Next 3Y12.26%
EPS Next 5Y-26.15%
Revenue Next Year7.59%
Revenue Next 2Y7.79%
Revenue Next 3Y8.24%
Revenue Next 5Y9.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTES Yearly Revenue VS EstimatesNTES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
NTES Yearly EPS VS EstimatesNTES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20 40 60

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.57 indicates a correct valuation of NTES.
NTES's Price/Earnings ratio is rather cheap when compared to the industry. NTES is cheaper than 83.75% of the companies in the same industry.
NTES is valuated rather cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.61, which indicates a correct valuation of NTES.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NTES indicates a rather cheap valuation: NTES is cheaper than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.46, NTES is valued a bit cheaper.
Industry RankSector Rank
PE 15.57
Fwd PE 14.61
NTES Price Earnings VS Forward Price EarningsNTES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NTES is valued a bit cheaper than the industry average as 77.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NTES indicates a rather cheap valuation: NTES is cheaper than 92.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.34
EV/EBITDA 9.51
NTES Per share dataNTES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NTES has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NTES's earnings are expected to grow with 12.26% in the coming years.
PEG (NY)0.76
PEG (5Y)0.89
EPS Next 2Y13.01%
EPS Next 3Y12.26%

5

5. Dividend

5.1 Amount

NTES has a Yearly Dividend Yield of 2.21%.
Compared to an average industry Dividend Yield of 8.00, NTES pays a better dividend. On top of this NTES pays more dividend than 91.25% of the companies listed in the same industry.
NTES's Dividend Yield is comparable with the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 2.21%

5.2 History

The dividend of NTES has a limited annual growth rate of 4.94%.
NTES has paid a dividend for at least 10 years, which is a reliable track record.
NTES has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years3
Div Non Decr Years3
NTES Yearly Dividends per shareNTES Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

36.47% of the earnings are spent on dividend by NTES. This is a low number and sustainable payout ratio.
DP36.47%
EPS Next 2Y13.01%
EPS Next 3Y12.26%
NTES Yearly Income VS Free CF VS DividendNTES Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
NTES Dividend Payout.NTES Dividend Payout, showing the Payout Ratio.NTES Dividend Payout.PayoutRetained Earnings

NETEASE INC-ADR

NASDAQ:NTES (12/29/2025, 9:54:28 AM)

137.96

-0.11 (-0.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-20 2025-11-20/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners10.4%
Inst Owner Change7.83%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap88.91B
Revenue(TTM)111.83B
Net Income(TTM)36.28B
Analysts83.89
Price Target167.93 (21.72%)
Short Float %1.48%
Short Ratio2.71
Dividend
Industry RankSector Rank
Dividend Yield 2.21%
Yearly Dividend2.5
Dividend Growth(5Y)4.94%
DP36.47%
Div Incr Years3
Div Non Decr Years3
Ex-Date12-05 2025-12-05 (0.57)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.48%
Min EPS beat(2)-2.68%
Max EPS beat(2)-2.28%
EPS beat(4)2
Avg EPS beat(4)8.52%
Min EPS beat(4)-2.68%
Max EPS beat(4)22.83%
EPS beat(8)3
Avg EPS beat(8)1.78%
EPS beat(12)6
Avg EPS beat(12)8.87%
EPS beat(16)10
Avg EPS beat(16)14.26%
Revenue beat(2)0
Avg Revenue beat(2)-4.28%
Min Revenue beat(2)-4.64%
Max Revenue beat(2)-3.91%
Revenue beat(4)0
Avg Revenue beat(4)-3.21%
Min Revenue beat(4)-4.64%
Max Revenue beat(4)-0.78%
Revenue beat(8)0
Avg Revenue beat(8)-3.59%
Revenue beat(12)0
Avg Revenue beat(12)-3.49%
Revenue beat(16)1
Avg Revenue beat(16)-2.65%
PT rev (1m)2.05%
PT rev (3m)6.6%
EPS NQ rev (1m)-0.73%
EPS NQ rev (3m)-2.81%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)-0.86%
Revenue NY rev (1m)-0.89%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 15.57
Fwd PE 14.61
P/S 5.58
P/FCF 13.34
P/OCF 12.75
P/B 3.99
P/tB 3.99
EV/EBITDA 9.51
EPS(TTM)8.86
EY6.42%
EPS(NY)9.44
Fwd EY6.85%
FCF(TTM)10.34
FCFY7.5%
OCF(TTM)10.82
OCFY7.85%
SpS24.74
BVpS34.56
TBVpS34.56
PEG (NY)0.76
PEG (5Y)0.89
Graham Number83.01
Profitability
Industry RankSector Rank
ROA 16.92%
ROE 23.22%
ROCE 21.49%
ROIC 17.58%
ROICexc 133.28%
ROICexgc 133.28%
OM 31.6%
PM (TTM) 32.45%
GM 63.47%
FCFM 41.82%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
ROICexc(3y)98.11%
ROICexc(5y)81.85%
ROICexgc(3y)117.55%
ROICexgc(5y)98.29%
ROCE(3y)19.38%
ROCE(5y)17.87%
ROICexgc growth 3Y31.39%
ROICexgc growth 5Y13.28%
ROICexc growth 3Y29.84%
ROICexc growth 5Y14.27%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.16
Debt/EBITDA 0.2
Cap/Depr 97.24%
Cap/Sales 1.93%
Interest Coverage 89.69
Cash Conversion 130.26%
Profit Quality 128.89%
Current Ratio 3.42
Quick Ratio 3.41
Altman-Z N/A
F-Score8
WACC9.1%
ROIC/WACC1.93
Cap/Depr(3y)107.89%
Cap/Depr(5y)102.75%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.4%
Profit Quality(3y)118.33%
Profit Quality(5y)132.69%
High Growth Momentum
Growth
EPS 1Y (TTM)29.11%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%26.66%
EPS Next Y20.61%
EPS Next 2Y13.01%
EPS Next 3Y12.26%
EPS Next 5Y-26.15%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%8.2%
Revenue Next Year7.59%
Revenue Next 2Y7.79%
Revenue Next 3Y8.24%
Revenue Next 5Y9.64%
EBIT growth 1Y23.42%
EBIT growth 3Y21.69%
EBIT growth 5Y16.49%
EBIT Next Year35.05%
EBIT Next 3Y18.68%
EBIT Next 5Y16.3%
FCF growth 1Y64.95%
FCF growth 3Y19.76%
FCF growth 5Y21.96%
OCF growth 1Y50.4%
OCF growth 3Y16.76%
OCF growth 5Y18.17%

NETEASE INC-ADR / NTES FAQ

What is the ChartMill fundamental rating of NETEASE INC-ADR (NTES) stock?

ChartMill assigns a fundamental rating of 7 / 10 to NTES.


What is the valuation status for NTES stock?

ChartMill assigns a valuation rating of 8 / 10 to NETEASE INC-ADR (NTES). This can be considered as Undervalued.


What is the profitability of NTES stock?

NETEASE INC-ADR (NTES) has a profitability rating of 9 / 10.


How financially healthy is NETEASE INC-ADR?

The financial health rating of NETEASE INC-ADR (NTES) is 8 / 10.


Can you provide the expected EPS growth for NTES stock?

The Earnings per Share (EPS) of NETEASE INC-ADR (NTES) is expected to grow by 20.61% in the next year.